Fig. 3.

Changes in generalized myasthenia gravis medication after starting eculizumab. ^a12 months after starting eculizumab, three patients had their daily prednisone doses reduced from 50 mg to 10 mg, 15 mg and 20 mg, respectively, two patients had their dose reduced from 40 mg to 10 mg (the sixth patient also had her dose reduced, from 30 mg to 10 mg); ^bIn the three patients who continued pyridostigmine treatment after eculizumab initiation, two had their dose reduced from 60 mg TID to 30 mg TID and one had her dose reduced from 60 mg QID to 60 mg TID; ^cFurther details of doses can be found in Table 1. IVIG, intravenous immunoglobulin; PLEX, plasma exchange; QID, four times daily; TID, three times daily.